Coronavirus / COVID

Those taking methotrexate had lower seroconversion rates compared to controls.

The number of deaths from malaria jumped by more than 100,000 in 2020 as antimalarial efforts were curtailed by the need to respond to the coronavirus disease 2019 pandemic.

A meeting between developers and federal experts was inconclusive to the necessity of a third mRNA dose for COVID-19.

The CDC announced 100 preliminary cases of Guillain-Barré syndrome following vaccine administration.

While infection risk is not eliminated, the vaccine still provided significant protection.

The second wave in South Africa was larger and saw the Beta lineage dominate.

Investigators followed patients with pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) for 6 months to review their outcomes.

This serious adverse event has been linked with COVID-19 shots from AstraZeneca and Janssen.

A Swiss population-based study showed more people in socioeconomically challenged places tested positive more frequently, saw higher hospitalizations, and greater mortality rates than those in higher socioeconomic places.

Azithromycin versus standard care in patients with mild-to-moderate COVID-19, did not reduce the risk of hospital admission or mortality.

Patients who developed atrial fibrillation had higher levels of two known markers of heart stress.

Interventions after students receive a positive test were ineffective at preventing more infections.

The agency is making the safe return to school in the fall their top priority.

The announcement aligns with an FDA and CDC statement against the need for booster doses.

Kansas counties that adopted mask mandates saw a 60% drop in COVID-19 cases, a new study found.

In the second installment of an interview, members of the FlowMetric Life Sciences' leadership discuss how their technology might aid possible COVID-19 vaccine booster shots, how immunocompromised patients respond to vaccines, and other vaccines where their platform may be used.

The Sinovac developed vaccine could greatly aid in the global inoculation effort.

A study looked at COVID-19 incidence rates in health care workers who wore medical masks vs respirator masks when performing nonaerosolizing, routine patient care.

Two doses of the Pfizer or AstraZeneca vaccines generated high sero-neutralization against the strain.

While the efficacy of SARS-CoV-2 vaccines have been demonstrated, a lack of data is present for patients with cancer.

FlowMetric, Inc., discusses its VaxEffect, an immune monitoring platform and how it can be used to measure COVID-19 vaccine responses.

Benefits were also observed among adults aged 18 to 49, with adults over 65 seeing the most benefit.

Research has shown that some receptors for the virus are linked to male hormones.

Patients receiving both IL-6 and corticosteroids showed lower risks of death and mechanical ventilation.

New study finds differences in testing, disease severity in England.